Works matching AU Xu, Ximing


Results: 230
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001).

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-024-01656-0
    By:
    • Chen, Hua-Jun;
    • Tu, Hai-Yan;
    • Hu, Yanping;
    • Fan, Yun;
    • Wu, Guowu;
    • Cang, Shundong;
    • Yang, Yi;
    • Yang, Nong;
    • Ma, Rui;
    • Jin, Gaowa;
    • Xu, Ximing;
    • Liu, Anwen;
    • Tang, Shubin;
    • Cheng, Ying;
    • Yu, Yan;
    • Xu, Chong-Rui;
    • Zhou, Qing;
    • Wu, Yi-Long
    Publication type:
    Article
    22
    23
    24

    Study and prediction of the 2022 global monkeypox epidemic.

    Published in:
    Journal of Biosafety & Biosecurity, 2022, v. 4, n. 2, p. 158, doi. 10.1016/j.jobb.2022.12.001
    By:
    • Fengying Wei;
    • Zhihang Peng;
    • Zhen Jin;
    • Jinjie Wang;
    • Ximing Xu;
    • Xinyan Zhang;
    • Jun Xu;
    • Zixiong Ren;
    • Yao Bai;
    • Xiaoli Wang;
    • Bulai Lu;
    • Zhaojun Wang;
    • Jianguo Xu;
    • Senzhong Huang
    Publication type:
    Article
    25
    26
    27

    Structures of a mammalian TRPM8 in closed state.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30919-y
    By:
    • Zhao, Cheng;
    • Xie, Yuan;
    • Xu, Lizhen;
    • Ye, Fan;
    • Xu, Ximing;
    • Yang, Wei;
    • Yang, Fan;
    • Guo, Jiangtao
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50